LCM

Lynx1 Capital Management Portfolio holdings

AUM $346M
1-Year Est. Return 2.97%
This Quarter Est. Return
1 Year Est. Return
-2.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$277M
AUM Growth
-$111M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
22
New
Increased
Reduced
Closed

Top Buys

1
+$20.1M
2
+$15M
3
+$7.65M
4
CGEM icon
Cullinan Oncology
CGEM
+$6.58M
5
ALLO icon
Allogene Therapeutics
ALLO
+$5.19M

Top Sells

1
+$89.3M
2
+$17.9M
3
+$11.9M
4
SLN
Silence Therapeutics
SLN
+$11.4M
5
AUTL
Autolus Therapeutics
AUTL
+$8.87M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$71.4M 25.76%
1,206,707
-302,300
2
$70.1M 25.27%
5,185,191
+1,488,371
3
$46.3M 16.69%
3,966,726
+656,163
4
$31.8M 11.47%
6,880,527
+3,245,865
5
$30.6M 11.03%
5,224,600
6
$6.58M 2.37%
+377,323
7
$5.19M 1.87%
+2,228,295
8
$4.52M 1.63%
+167,317
9
$4.02M 1.45%
252,881
+10,587
10
$3.68M 1.33%
492,103
-1,590,870
11
$1.77M 0.64%
840,763
+240,763
12
$460K 0.17%
49,973
-17,899
13
$427K 0.15%
43,499
-66,241
14
$177K 0.06%
+9,500
15
$157K 0.06%
17,400
16
$129K 0.05%
+3,800
17
$31.9K 0.01%
+16,194
18
– –
-1,390,160
19
– –
-1,981,106
20
– –
-137,923
21
– –
-526,642
22
– –
-2,253,183